Lingkang Pharmaceutical: Holding shareholder's 49.65 million shares of stock have been released from pledge.

Lingkang Pharmaceuticals announced that on February 10, 2026, its controlling shareholder Lingkang Holdings released part of its pledged shares, totaling 49.65 million shares, accounting for 14.62% of the total shares held by the company and 6.89% of the total share capital of the company. Lingkang Holdings directly and indirectly holds 339.65 million shares of the company, accounting for 47.09% of the total share capital of the company. After the release of the pledge, the remaining number of pledged shares is 54 million shares, accounting for 15.90% of its shareholding and 7.49% of the total share capital of the company. It has been confirmed that there is no subsequent pledge plan for the released shares.